Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Menu

    Dalbavancin

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 128,762Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    FDA Confirms Paragraph IV Patent Litigation for Dalbavancin Hydrochloride
    FDA Confirms Paragraph IV Patent Litigation for Dalbavancin Hydrochloride

    08 Aug 2023

    // FDA

    https://www.pharmacompass.com/pdf/news/fda-confirms-paragraph-iv-patent-litigation-for-dalbavancin-hydrochloride-98816.pdf

    FDA
    08 Aug 2023
    Share Share
    Paladin Labs Launches of Xydalba (dalbavancin for injection) in Canada
    Paladin Labs Launches of Xydalba (dalbavancin for injection) in Canada

    18 Jan 2022

    // YAHOO FINANCE

    https://finance.yahoo.com/news/paladin-labs-announces-launch-xydalba-123000837.html

    YAHOO FINANCE
    18 Jan 2022
    Share Share
    Trial of existing antibiotic for treating Staphylococcus aureus bacteremia
    Trial of existing antibiotic for treating Staphylococcus aureus bacteremia

    27 Apr 2021

    // NIH

    https://www.nih.gov/news-events/news-releases/trial-existing-antibiotic-treating-staphylococcus-aureus-bacteremia-begins

    NIH
    27 Apr 2021
    Share Share
    Global MRSA Drugs Market to Surpass US$ 1.3 Billion by 2026
    Global MRSA Drugs Market to Surpass US$ 1.3 Billion by 2026

    24 Sep 2019

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20190924005553/en

    BUSINESSWIRE
    24 Sep 2019
    Share Share
    Correvio Highlights FDA Acceptance of United Therapeutics' Trevyent NDA
    Correvio Highlights FDA Acceptance of United Therapeutics' Trevyent NDA

    11 Sep 2019

    // BIOSPACE

    https://www.biospace.com/article/releases/correvio-highlights-fda-acceptance-of-united-therapeutics-trevyent-new-drug-application/?s=95

    BIOSPACE
    11 Sep 2019
    Share Share
    Spero Therapeutics Appoints David Melnick, M.D., as Chief Medical Officer
    Spero Therapeutics Appoints David Melnick, M.D., as Chief Medical Officer

    04 Jun 2018

    // PRESS RELEASE

    https://investors.sperotherapeutics.com/news-releases/news-release-details/spero-therapeutics-appoints-david-melnick-md-chief-medical

    PRESS RELEASE
    04 Jun 2018
    Share Share